Concepedia

Yoshiko Okita

YO

40

Publications

1.8K

Citations

25

H-Index

2008

Active since

Affiliations

The University of Osaka(Current)

Osaka National Hospital

Osaka International Cancer Institute

Wakayama Medical University

Osaka City University

Yoshiko Okita is an author at The University of Osaka specializing in medicine, neuro-oncology, and glioma.

ORCID

Top concepts

Publications per year

2008–2024

40

Publications

40

A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas

Hideyuki Arita, Kai Yamasaki, Yuko Matsushita et al. · Acta Neuropathologica Communications · 2016 · 257 citations · Full text

Slower growth of skull base meningiomas compared with non–skull base meningiomas based on volumetric and biological studies

Naoya Hashimoto, Carter S. Rabo, Yoshiko Okita et al. · Journal of neurosurgery · 2011 · 153 citations · Full text

TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastoma

Kenji Fujimoto, Hideyuki Arita, Kaishi Satomi et al. · Acta Neuropathologica · 2021 · 103 citations

, , +9

Lesion location implemented magnetic resonance imaging radiomics for predicting IDH and TERT promoter mutations in grade II/III gliomas

Hideyuki Arita, Manabu Kinoshita, Atsushi Kawaguchi et al. · Scientific Reports · 2018 · 98 citations · Full text

Radiomics and MGMT promoter methylation for prognostication of newly diagnosed glioblastoma

Takahiro Sasaki, Manabu Kinoshita, Koji Fujita et al. · Scientific Reports · 2019 · 79 citations · Full text

Rows per page

1–5 of 40